Filing Details
- Accession Number:
- 0001567619-19-022982
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-12 16:25:09
- Reporting Period:
- 2019-12-10
- Accepted Time:
- 2019-12-12 16:25:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
827809 | Novelion Therapeutics Inc. | NVLNF | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1370042 | Stonepine Capital, L.p. | 919 Nw Bond Street, Suite 204 Bend OR 97703 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-12-10 | 5,202 | $0.69 | 3,908,167 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-12-11 | 40 | $0.69 | 3,908,207 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-12-12 | 1,000 | $0.70 | 3,909,207 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |